Pharmacokinetics of Procaterol in Elite Athletes

The purpose of the study is to find blood and urine concentrations of procaterol administrated either by inhalation or by tablets in asthmatic and non-asthmatics males. We hypotheis that the concentrations of procaterol in the blood and serum is higher after tablet intake versus inhalation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Asthma Bronchial Diseases Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Respiratory Hypersensitivity Respiratory Tract Diseases

Age range

18 year–45 year

Sex eligibility

Male

Study type

Observational

Primary location

Bispebjerg Hospital

Copenhagen, DK-2400, Denmark

About this study

Doping study

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Doctor diagnosed asthma for the asthmatic group
GINA 1-3 for the asthmatic group
Use of beta2-agonist for at least 12 months for the asthmatic group
age 18-45
males
informed consent

Exclusion criteria

smoker or former smoker
airway infection to weeks prior to the study or during the study
other chronic diseaes than asthma and allergy
Use of beta2-agonist 6 days prior to the study
Allergy to the study medicine

Treatment and study plan

Primary outcomes

urine concentration of drug 0-24 h

Time frame: 7 days

In healthy subjects to investigate drug farmakokenetic
serum concentration of drug 0-24 h

Time frame: 7 days

In healthy subjects to investigate drug farmakokenetic

Sponsors and collaborators

Lead sponsor

Bispebjerg Hospital

Other

Registry information

Official study title

Procaterol in Elite Athletes - a PK Study

Acronym: Procat

Important dates

Study start: 2011
Primary completion: 2013
Study completion: 2013
First posted: Mar 1, 2023
Registry last updated: Mar 1, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed